Skip to main content
Top
Published in: Italian Journal of Pediatrics 1/2014

Open Access 01-12-2014 | Research

In-hospital management of children with bacterial meningitis in Italy

Authors: Marta Ciofi degli Atti, Susanna Esposito, Luciana Parola, Lucilla Ravà, Gianluigi Gargantini, Riccardo Longhi, the GSAQ working group

Published in: Italian Journal of Pediatrics | Issue 1/2014

Login to get access

Abstract

Background

Over the years 2009-2013, we conducted a prospective study within a network established by the Italian Society of Pediatrics to describe the in-hospital management of children hospitalized for acute bacterial meningitis in 19 Italian hospitals with pediatric wards.

Methods

Hospital adherence to the study was voluntary; data were derived from clinical records. Information included demographic data, dates of onset of first symptoms, hospitalization and discharge; diagnostic evaluation; etiology; antimicrobial treatment; treatment with dexamethasone; in-hospital complications; neurological sequelae and status at hospital discharge. Characteristics of in-hospital management of patients were described by causative agent.

Results

Eighty-five patients were identified; 49.4% had received an antimicrobial treatment prior to admission. Forty percent of patients were transferred from other Centers; the indication to seek for hospital care was given by the primary care pediatrician in 80% of other children. Etiological agent was confirmed in 65.9% of cases; the most common infectious organism was Neisseria meningitidis (34.1%), followed by Streptococcus pneumoniae (20%). Patients with pneumococcal meningitis had a significant longer interval between onset of first symptoms and hospital admission. Median interval between the physician suspicion of meningitis and in-hospital first antimicrobial dose was 1 hour (interquartile range [IQR]: 1-2 hours). Corticosteroids were given to 63.5% of cases independently of etiology; 63.0% of treated patients received dexamethasone within 1 hour of antibiotic treatment, and 41.2% were treated for ≤4 days. Twenty-nine patients reported at least one in-hospital complication (34.1%). Six patients had neurological sequelae at discharge (7.1%). No deaths were observed.

Conclusions

We observed a rate of meningitis sequelae at discharge similar to that reported by other western countries. Timely assistance and early treatment could have contributed to the favorable outcome that was observed in the majority of cases. Adherence to recommendation for corticosteroid adjunctive therapy seems suboptimal, and should be investigated in further studies. Most meningitis cases were due to N. meningitidis and S. pneumoniae. Reaching and maintaining adequate vaccination coverage against pneumococcal and meningococcal invasive infections remains a priority to prevent bacterial meningitis cases.
Literature
1.
go back to reference Peltola H: Worldwide Haemophilus influenzae type b diseases at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000, 13: 302-317. 10.1128/CMR.13.2.302-317.2000.PubMedCentralCrossRefPubMed Peltola H: Worldwide Haemophilus influenzae type b diseases at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000, 13: 302-317. 10.1128/CMR.13.2.302-317.2000.PubMedCentralCrossRefPubMed
2.
go back to reference Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, Farley MM, Jorgensen JH, Lexau CA, Petit S, Reingold A, Schaffner W, Thomas A, Whitney CG, Harrison LH: Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009, 360: 244-256. 10.1056/NEJMoa0800836.PubMedCentralCrossRefPubMed Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, Farley MM, Jorgensen JH, Lexau CA, Petit S, Reingold A, Schaffner W, Thomas A, Whitney CG, Harrison LH: Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009, 360: 244-256. 10.1056/NEJMoa0800836.PubMedCentralCrossRefPubMed
3.
go back to reference Trotter CL, Chandra M, Cano R, Larrauri A, Ramsay ME, Brehony C, Jolley KA, Maiden MC, Heuberger S, Frosch M: A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev. 2007, 31: 27-36. 10.1111/j.1574-6976.2006.00060.x.CrossRefPubMed Trotter CL, Chandra M, Cano R, Larrauri A, Ramsay ME, Brehony C, Jolley KA, Maiden MC, Heuberger S, Frosch M: A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev. 2007, 31: 27-36. 10.1111/j.1574-6976.2006.00060.x.CrossRefPubMed
5.
go back to reference Alfonsi V, D’Ancona F, Giambi C, Nacca G, Rota MC: Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy. 2011, 103: 176-183. 10.1016/j.healthpol.2011.10.002.CrossRefPubMed Alfonsi V, D’Ancona F, Giambi C, Nacca G, Rota MC: Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy. 2011, 103: 176-183. 10.1016/j.healthpol.2011.10.002.CrossRefPubMed
7.
go back to reference Miner JR, Heegaard W, Mapes A, Biros M: Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med. 2001, 4: 387-392. 10.1016/S0736-4679(01)00407-3.CrossRef Miner JR, Heegaard W, Mapes A, Biros M: Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med. 2001, 4: 387-392. 10.1016/S0736-4679(01)00407-3.CrossRef
8.
go back to reference Køster-Rasmussen R, Korshin A, Meyer CN: Antibiotic treatment delay and outcome in acute bacterial meningitis. J Infect. 2008, 57: 449-454. 10.1016/j.jinf.2008.09.033.CrossRefPubMed Køster-Rasmussen R, Korshin A, Meyer CN: Antibiotic treatment delay and outcome in acute bacterial meningitis. J Infect. 2008, 57: 449-454. 10.1016/j.jinf.2008.09.033.CrossRefPubMed
9.
go back to reference Management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care. 2010, National Institute for Health and Clinical Excellence (NICE), London (UK) Management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care. 2010, National Institute for Health and Clinical Excellence (NICE), London (UK)
10.
go back to reference Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ: Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004, 39: 1267-1284. 10.1086/425368.CrossRefPubMed Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ: Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004, 39: 1267-1284. 10.1086/425368.CrossRefPubMed
11.
go back to reference van de Beek D, de Gans J, Spanjaard L, Vermeulen M, Dankert J: Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J Antimicrob Chemother. 2002, 49: 661-666. 10.1093/jac/49.4.661.CrossRefPubMed van de Beek D, de Gans J, Spanjaard L, Vermeulen M, Dankert J: Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J Antimicrob Chemother. 2002, 49: 661-666. 10.1093/jac/49.4.661.CrossRefPubMed
12.
go back to reference Cullen MM: An audit of the investigation and initial management of adults presenting with possible bacterial meningitis. J Infect. 2005, 50: 120-124. 10.1016/j.jinf.2003.11.016.CrossRefPubMed Cullen MM: An audit of the investigation and initial management of adults presenting with possible bacterial meningitis. J Infect. 2005, 50: 120-124. 10.1016/j.jinf.2003.11.016.CrossRefPubMed
13.
go back to reference Stockdale AJ, Weekes MP, Aliyu SH: An audit of acute bacterial meningitis in a large teaching hospital 2005-10. QJM. 2011, 104: 1055-1063. 10.1093/qjmed/hcr123.CrossRefPubMed Stockdale AJ, Weekes MP, Aliyu SH: An audit of acute bacterial meningitis in a large teaching hospital 2005-10. QJM. 2011, 104: 1055-1063. 10.1093/qjmed/hcr123.CrossRefPubMed
14.
go back to reference Kelly C, Sohal A, Michael BD, Riordan A, Solomon T, Kneen R: Suboptimal management of central nervous system infections in children: a multi-centre retrospective study. BMC Pediatr. 2012, 12: 14-10.1186/1471-2431-12-145.CrossRef Kelly C, Sohal A, Michael BD, Riordan A, Solomon T, Kneen R: Suboptimal management of central nervous system infections in children: a multi-centre retrospective study. BMC Pediatr. 2012, 12: 14-10.1186/1471-2431-12-145.CrossRef
15.
go back to reference Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I: Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010, 10: 317-328. 10.1016/S1473-3099(10)70048-7.CrossRefPubMed Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I: Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010, 10: 317-328. 10.1016/S1473-3099(10)70048-7.CrossRefPubMed
16.
go back to reference Vasilopoulou VA, Karanika M, Theodoridou K, Katsioulis AT, Theodoridou MN, Hadjichristodoulou CS: Prognostic factors related to sequelae in childhood bacterial meningitis: data from a Greek meningitis registry. BMC Infect Dis. 2011, 11: 214-10.1186/1471-2334-11-214.PubMedCentralCrossRefPubMed Vasilopoulou VA, Karanika M, Theodoridou K, Katsioulis AT, Theodoridou MN, Hadjichristodoulou CS: Prognostic factors related to sequelae in childhood bacterial meningitis: data from a Greek meningitis registry. BMC Infect Dis. 2011, 11: 214-10.1186/1471-2334-11-214.PubMedCentralCrossRefPubMed
17.
go back to reference Kim KS: Acute bacterial meningitis in infants and children. Lancet Infect Dis. 2010, 10: 32-42. 10.1016/S1473-3099(09)70306-8.CrossRefPubMed Kim KS: Acute bacterial meningitis in infants and children. Lancet Infect Dis. 2010, 10: 32-42. 10.1016/S1473-3099(09)70306-8.CrossRefPubMed
18.
go back to reference Stockmann CI, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT: Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics. 2013, 132: 421-428. 10.1542/peds.2013-0621.PubMedCentralCrossRefPubMed Stockmann CI, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT: Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics. 2013, 132: 421-428. 10.1542/peds.2013-0621.PubMedCentralCrossRefPubMed
19.
go back to reference Azzari C, Moriondo M, Cortimiglia M, Valleriani C, Canessa C, Indolfi G, Ricci S, Nieddu F, de Martino M, Resti M: Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children. Vaccine. 2012, 30: 2701-2705. 10.1016/j.vaccine.2011.12.008.CrossRefPubMed Azzari C, Moriondo M, Cortimiglia M, Valleriani C, Canessa C, Indolfi G, Ricci S, Nieddu F, de Martino M, Resti M: Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children. Vaccine. 2012, 30: 2701-2705. 10.1016/j.vaccine.2011.12.008.CrossRefPubMed
20.
go back to reference Surveillance of invasive bacterial diseases in Europe, 2011. 2013, ECDC, Stockholm Surveillance of invasive bacterial diseases in Europe, 2011. 2013, ECDC, Stockholm
21.
go back to reference Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, Serruto D, Comanducci M, Boccadifuoco G, Donnelly JJ, Medini D, Borrow R: Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis. 2013, 13: 416-425. 10.1016/S1473-3099(13)70006-9.CrossRefPubMed Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, Serruto D, Comanducci M, Boccadifuoco G, Donnelly JJ, Medini D, Borrow R: Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis. 2013, 13: 416-425. 10.1016/S1473-3099(13)70006-9.CrossRefPubMed
22.
go back to reference Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 2012, ECDC, Stockholm Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 2012, ECDC, Stockholm
23.
go back to reference Gherardi G, D’Ambrosio F, Visaggio D, Dicuonzo G, Del Grosso M, Pantosti A: Serotype and clonal evolution of penicillin-nonsusceptible invasive Streptococcus pneumoniae in the 7-valent pneumococcal conjugate vaccine era in Italy. Antimicrob Agents Chemother. 2012, 56: 4965-4968. 10.1128/AAC.00830-12.PubMedCentralCrossRefPubMed Gherardi G, D’Ambrosio F, Visaggio D, Dicuonzo G, Del Grosso M, Pantosti A: Serotype and clonal evolution of penicillin-nonsusceptible invasive Streptococcus pneumoniae in the 7-valent pneumococcal conjugate vaccine era in Italy. Antimicrob Agents Chemother. 2012, 56: 4965-4968. 10.1128/AAC.00830-12.PubMedCentralCrossRefPubMed
24.
go back to reference Brouwer MC, McIntyre P, Prasad K, van de Beek D: Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2013, 6: Brouwer MC, McIntyre P, Prasad K, van de Beek D: Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2013, 6:
Metadata
Title
In-hospital management of children with bacterial meningitis in Italy
Authors
Marta Ciofi degli Atti
Susanna Esposito
Luciana Parola
Lucilla Ravà
Gianluigi Gargantini
Riccardo Longhi
the GSAQ working group
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2014
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-014-0087-1

Other articles of this Issue 1/2014

Italian Journal of Pediatrics 1/2014 Go to the issue